Stay updated on Selonsertib for NASH F3 Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selonsertib for NASH F3 Fibrosis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added a MedlinePlus Genetics topic: Non-alcoholic fatty liver disease, and updated the page revision from v3.0.1 to v3.0.2. The 'Back to Top' element was removed as a minor navigation change.
    Difference
    0.2%
    Check dated 2025-09-12T00:46:35.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page has updated its location reference from 'Tuen Mun, Hong Kong' to 'Tuenmen, Hong Kong' and has changed the version from v3.0.0 to v3.0.1.
    Difference
    0.3%
    Check dated 2025-09-04T21:58:47.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information for Crizanlizumab and related topics such as Fatty Liver Disease, along with a revision to version 3.0.0. Additionally, several locations have been added while others have been removed, indicating a significant update in the geographical context of the content.
    Difference
    14%
    Check dated 2025-08-28T16:12:56.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-14T12:44:06.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.9 to version 2.16.11, indicating a revision in the content or features of the page.
    Difference
    0.0%
    Check dated 2025-08-07T08:19:46.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.9, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.5%
    Check dated 2025-07-31T07:05:47.000Z thumbnail image

Stay in the know with updates to Selonsertib for NASH F3 Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.